Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (91-100 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 10, 2019
Tumor microenvironment determines drug efficacy in vitro - apoptotic and anti-inflammatory effects of 15-lipoxygenase metabolite, 13-HpOTrEChristopher Wolff, Christian Zoschke, Suresh Kumar Kalangi, et al.
Journal of the American Academy of Dermatology|February 1, 1990
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administrationM Schäfer-Korting, H C Korting, A Lukacs, et al.
The British Journal of Dermatology|July 1, 1995
Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblastsH C Korting, E Hülsebus, M Kerscher, et al.
American Journal of Clinical Dermatology|April 12, 2006
Receptor-selective retinoids for psoriasis: focus on tazaroteneGünther Weindl, Alexander Roeder, Monika Schäfer-Korting, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteersH C Korting, M Schäfer-Korting, L Maass, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 5, 2014
Suitability of skin integrity tests for dermal absorption studies in vitroKatharina Guth, Monika Schäfer-Korting, Eric Fabian, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Targeting human DNA polymerase alpha for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand bindingAnja Richartz, Monika Höltje, Birte Brandt, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetilH C Korting, M Schäfer-Korting, F Kees, et al.
The Journal of Investigative Dermatology|March 22, 2003
Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healingRüdiger Vogler, Bettina Sauer, Dong-Seok Kim, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro studyM Schäfer-Korting, H C Korting, F Amann, et al.
Pageof 22

Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 10, 2019
Tumor microenvironment determines drug efficacy in vitro - apoptotic and anti-inflammatory effects of 15-lipoxygenase metabolite, 13-HpOTrEChristopher Wolff, Christian Zoschke, Suresh Kumar Kalangi, et al.
Journal of the American Academy of Dermatology|February 1, 1990
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administrationM Schäfer-Korting, H C Korting, A Lukacs, et al.
The British Journal of Dermatology|July 1, 1995
Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblastsH C Korting, E Hülsebus, M Kerscher, et al.
American Journal of Clinical Dermatology|April 12, 2006
Receptor-selective retinoids for psoriasis: focus on tazaroteneGünther Weindl, Alexander Roeder, Monika Schäfer-Korting, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteersH C Korting, M Schäfer-Korting, L Maass, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 5, 2014
Suitability of skin integrity tests for dermal absorption studies in vitroKatharina Guth, Monika Schäfer-Korting, Eric Fabian, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Targeting human DNA polymerase alpha for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand bindingAnja Richartz, Monika Höltje, Birte Brandt, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetilH C Korting, M Schäfer-Korting, F Kees, et al.
The Journal of Investigative Dermatology|March 22, 2003
Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healingRüdiger Vogler, Bettina Sauer, Dong-Seok Kim, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro studyM Schäfer-Korting, H C Korting, F Amann, et al.
Pageof 22